Liminatus Pharma, Inc.
LIMN
$0.14
$0.013.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.91M | 337.70K | 724.50K | 1.34M | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 870.90K | 162.90K | 478.90K | 444.10K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.78M | 500.60K | 1.20M | 1.78M | -- |
|
|
|||||
| Total Current Assets | 2.78M | 500.60K | 1.20M | 1.78M | -- |
| Net Property, Plant & Equipment | 11.70K | 12.20K | 12.80K | 200.00 | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 126.30K | 126.30K | -- |
| Total Assets | 2.79M | 512.80K | 1.34M | 1.91M | -- |
|
|
|||||
| Total Accounts Payable | 529.80K | 582.20K | 559.20K | 431.90K | -- |
| Total Accrued Expenses | 222.60K | 203.90K | 184.90K | 165.80K | 1.10K |
| Short-term Debt | 1.44M | 1.44M | 1.44M | 1.44M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 694.60K | 8.07M | 678.10K | 8.48M | -- |
| Total Other Current Liabilities | 694.60K | 8.07M | 678.10K | 8.48M | -- |
| Total Current Liabilities | 2.89M | 10.30M | 2.86M | 10.52M | 1.10K |
|
|
|||||
| Total Current Liabilities | 2.89M | 10.30M | 2.86M | 10.52M | 1.10K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.44M | 1.44M | 1.44M | 1.44M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 33.40K | 29.20K | 123.60K | 200.50K | -- |
| Total Liabilities | 2.92M | 10.33M | 2.99M | 10.72M | 1.10K |
|
|
|||||
| Common Stock & APIC | 39.86M | 29.06M | 29.06M | 20.07M | 0.00 |
| Retained Earnings | -40.00M | -38.87M | -30.70M | -28.88M | -1.10K |
| Treasury Stock & Other | -- | -- | -- | -- | 0.00 |
| Total Common Equity | -132.60K | -9.81M | -1.65M | -8.81M | -1.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -132.60K | -9.81M | -1.65M | -8.81M | -1.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -132.60K | -9.81M | -1.65M | -8.81M | -1.10K |
|
|
|||||